Shaheen Zakaria1, Amy C Degnim
1Department of Surgery, Mayo Clinic and Mayo Foundation, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Prophylactic mastectomy (PM) may be considered for high-risk women, including BRCA gene carriers, to reduce breast cancer risk. However, PM remains controversial due to a lack of randomized controlled trials on its benefits and harms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: